A research collaboration has published a comprehensive overview of how our immune system reshapes tumor architecture in response to immune checkpoint therapy. The eight-year study outlines how cancer ...
Mutations in the ‘C9orf72’ gene cause progressive neurodegenerative diseases, namely Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
In mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin lymphoma, TP53 mutations are known to affect patients’ prognosis—but questions remain. What does the heterogeneity of TP53 ...
A Cleveland Clinic-led research collaboration between Timothy Chan, MD, PhD, Chair of Cleveland Clinic’s Global Center for Immunotherapy, and Bristol Myers Squibb has published the most comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results